🔎 Trials Near Me

Gara Jalqabaatti › Rhabdomyosarcoma › Texas

Qorannoo klinikaalii Rhabdomyosarcoma Texas keessatti

Qorannoo 9 Rhabdomyosarcoma f Texas keessatti hirmaatuu jiru.

Magaalota Texas keessatti

Takkalaa qorannoo (Ingiliffa)

Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors

  • University of Texas - MD Anderson Cancer Center, Houston
Namoota walitti qabaa jiraSadarkaa 1
24 Months – 18 Years · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06441331

Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors

  • Children's Medical Center, Dallas
Namoota walitti qabaa jiraSadarkaa 1/2
Hanga umuriin 30 · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT06541262

A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)

  • Dell Children's Medical Center of Central Texas, Austin
  • Driscoll Children's Hospital, Corpus Christi
  • UT Southwestern/Simmons Cancer Center-Dallas, Dallas
  • fi 2 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Hanga umuriin 50 · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT07466316

Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors

  • Texas Children's Hospital, Houston
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 1 hanga 21 · Saalaa hunda · Haaromfame 06-Hag-2026 · NCT04715191

PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors

  • Texas Children's Hospital, Houston
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 1 hanga 30 · Saalaa hunda · Haaromfame 22-Ado-2026 · NCT06721689

Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk Disease

  • Cook Children's Medical Center, Fort Worth
Namoota walitti qabaa jiraSadarkaa 2
Hanga umuriin 22 · Saalaa hunda · Haaromfame 15-Wax-2026 · NCT06023641

VITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid Tumors

  • The University of Texas Southwestern Medical Center, Dallas
  • Texas Children's Hospital, Houston
Namoota walitti qabaa jiraSadarkaa 1/2
6 Months – 30 Years · Saalaa hunda · Haaromfame 02-Wax-2026 · NCT04796012

HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma

  • Texas Children's Hospital, Houston
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 1 hanga 25 · Saalaa hunda · Haaromfame 22-Ama-2026 · NCT04995003

Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells

  • Houston Methodist Hospital, Houston
Namoota walitti qabaa jiraSadarkaa 1
Hanga umuriin 21 · Saalaa hunda · Haaromfame 03-Sad-2025 · NCT06198296

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.